Your brain doesn't have to age on autopilot. New research shows we can slow—and potentially reverse—brain aging.
Taking lipoic acid failed to ease progressive MS symptoms in a clinical trial, but the antioxidant showed signs of slowing ...
Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...
Study Finds on MSN
You recovered from COVID, but did your brain? New scans raise questions
Study Shows Structural Differences In COVID Patients Months After Infection, Even Among Those Who ‘Feel Fine’ In A Nutshell The study can’t determine if these brain changes are permanent, progressive, ...
Brain volume loss is a key marker of degeneration in multiple sclerosis, correlated with future disability progression. Ponesimod, alemtuzumab, teriflunomide, ozanimod, and fingolimod significantly ...
New research reveals that air pollution, especially PM2.5, may contribute to cerebral atrophy but does not seem to impair cognitive function. Urbanization affects the strength of this link. Study: ...
MELBOURNE, Australia and SAN FRANCISCO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback